RT Journal Article SR Electronic T1 Geospatial Analysis of Multilevel Socio-environmental Factors Impacting the Campylobacter Burden Among Infants in Rural Eastern Ethiopia: A One Health Perspective JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.07.03.24309853 DO 10.1101/2024.07.03.24309853 A1 Li, Xiaolong A1 Chen, Dehao A1 Liang, Song A1 Hassen, Jemal Yousuf A1 McKune, Sarah L. A1 Havelaar, Arie H. A1 Blackburn, Jason K. A1 , YR 2024 UL http://medrxiv.org/content/early/2024/07/04/2024.07.03.24309853.abstract AB Increasing attention has focused on health outcomes of Campylobacter infections among children under five years in low-resource settings. Recent evidence suggests colonization of Campylobacter species contributes to environmental enteric dysfunction, malnutrition, and growth faltering in young children. Campylobacter species are zoonotic, and factors from humans, animals, and the environment are involved in transmission. Few studies have assessed geospatial effects of environmental factors along with human and animal factors on Campylobacter infections. Here, we leveraged Campylobacter Genomics and Environmental Enteric Dysfunction (CAGED) project data to model multiple socio-environmental factors on Campylobacter burden among infants in Eastern Ethiopia. Stool samples from 106 infants were collected monthly from birth through the first year of life (December 2020 – June 2022). Genus-specific Taqman real-time PCR was performed to detect and quantify Campylobacter spp. and calculate cumulative Campylobacter burden for each child as the outcome variable. Thirteen regional environmental covariates describing topography, climate, vegetation, soil, and human population density were combined with household demographics, livelihoods/wealth, livestock ownership, and child-animal interactions as explanatory variables. We dichotomized all continuous outcome and explanatory variables and built logistic regression models for the first and second half of the infant’s first year of life. Infants being female, living in households with cattle, reported to have physical contact with animals, or reported to have mouthed soil or animal feces had increased odds of higher cumulative Campylobacter burden in Eastern Ethiopia. Future interventions should focus on infant-specific transmission pathways and create adequate separation of domestic animals from humans to prevent potential fecal exposures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project is funded by the United States Agency for International Development Bureau for Food Security under Agreement #AID-OAA-L-15-00003 as part of Feed the Future Innovation Lab for Livestock Systems, and by the Bill & Melinda Gates Foundation OPP#1175487. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Any opinions, findings, conclusions or recommendations expressed here are those of the authors alone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Internal Review Board of the University of Florida (IRB201903141); the Institutional Health Research Ethics Committee at Haramaya University (COHMS/1010/3796/20), and the Ethiopia National Research Ethics Review Committee (SM/14.1/1059/20) each gave approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDeidentified individual participant data will be made available through Dataverse (https://dataverse.org/) after December 31, 2024.